Avitinib
100 mg
| 100.00%
TargetMol
Avitinib, also known as AC0010 or AC0010MA, is an orally available, irreversible, epidermal growth factor receptor (EGFR) mutant-selective inhibitor, with potential antineoplastic activity. Upon oral administration, avitinib covalently binds to and inhibits the activity of mutant forms of EGFR, including the drug-resistant T790M EGFR mutant, which prevents signaling mediated by mutant forms of EGFR. This […]
More Information
Supplier Page
TargetMol
Bendazac L-lysine (Bendazaco lisina) is an agent introduced for the management of cataracts, protecting the level of vision in patients, thus delaying the need for surgical intervention.
More Information
Supplier Page
BML-284
25 mg
| 99.66%
TargetMol
TargetMol
TargetMol
TargetMol
Isoimperatorin
25 mg
| Purity Not Available
TargetMol
Isoimperatorin is an anti-inflammatory agent, exhibits significant inhibitory effects on acetylcholinesterase (AChE).
More Information
Supplier Page
Isoimperatorin
50 mg
| Purity Not Available
TargetMol
Isoimperatorin is an anti-inflammatory agent, exhibits significant inhibitory effects on acetylcholinesterase (AChE).
More Information
Supplier Page
Osthole
100 mg
| Purity Not Available
TargetMol
Osthole, a potential inhibitor of histamine H1 receptor, has been shown to stimulate osteoblast proliferation and differentiation.
More Information
Supplier Page
TargetMol